Lancet. 2000 Apr 1;355(9210):1158-9.

Survival after introduction of HAART in people with known duration of HIV-1 infection. The CASCADE Collaboration. Concerted Action on SeroConversion to AIDS and Death in Europe.

[No authors listed]

Abstract

We compared survival from HIV-1 seroconversion before and during the periods of highly-active antiretroviral therapy (HAART). Survival expectations were substantially better for HIV-1-infected individuals in 1997-98 (HAART period) compared with those in 1986-96 (pre-HAART period). Estimated survival 10 years from seroconversion was also substantially better in the later period.

PMID:: 10791383; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe. [Lancet. 2000]
Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe.
[No authors listed]Lancet. 2000 Apr 1; 355(9210):1131-7.
Determinants of survival following HIV-1 seroconversion after the introduction of HAART. [Lancet. 2003]
Determinants of survival following HIV-1 seroconversion after the introduction of HAART.
Porter K, Babiker A, Bhaskaran K, Darbyshire J, Pezzotti P, Porter K, Walker AS, CASCADE Collaboration. Lancet. 2003 Oct 18; 362(9392):1267-74.
Changes in the uptake of antiretroviral therapy and survival in people with known duration of HIV infection in Europe: results from CASCADE. [HIV Med. 2000]
Changes in the uptake of antiretroviral therapy and survival in people with known duration of HIV infection in Europe: results from CASCADE.
CASCADE (Concerted Action on SeroConversion to AIDS and Death in Europe) Collaboration. HIV Med. 2000 Oct; 1(4):224-31.
Review HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis. [Lancet. 2006]
Review HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis.
May MT, Sterne JA, Costagliola D, Sabin CA, Phillips AN, Justice AC, Dabis F, Gill J, Lundgren J, Hogg RS, et al. Lancet. 2006 Aug 5; 368(9534):451-8.
Review Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. [Verh K Acad Geneeskd Belg. 2001]
Review Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K. Verh K Acad Geneeskd Belg. 2001; 63(5):447-73.

See reviews... See all...

Cited by 17 PubMed Central articles

The spectrum of cancers in West Africa: associations with human immunodeficiency virus. [PLoS One. 2012]
The spectrum of cancers in West Africa: associations with human immunodeficiency virus.
Tanon A, Jaquet A, Ekouevi DK, Akakpo J, Adoubi I, Diomande I, Houngbe F, Zannou MD, Sasco AJ, Eholie SP, et al. PLoS One. 2012; 7(10):e48108. Epub 2012 Oct 29.
Patterns, trends and sex differences in HIV/AIDS reported mortality in Latin American countries: 1996-2007. [BMC Public Health. 2011]
Patterns, trends and sex differences in HIV/AIDS reported mortality in Latin American countries: 1996-2007.
Gonzalez MA, Martin L, Munoz S, Jacobson JO. BMC Public Health. 2011 Jul 29; 11:605. Epub 2011 Jul 29.
Gender differences in retention and survival on antiretroviral therapy of HIV-1 infected adults in Malawi. [Malawi Med J. 2010]
Gender differences in retention and survival on antiretroviral therapy of HIV-1 infected adults in Malawi.
Taylor-Smith K, Tweya H, Harries A, Schoutene E, Jahn A. Malawi Med J. 2010 Jun; 22(2):49-56.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Survival after introduction of HAART in people with known duration of HIV-1 infe...
Survival after introduction of HAART in people with known duration of HIV-1 infection. The CASCADE Collaboration. Concerted Action on SeroConversion to AIDS and Death in Europe.
Lancet. 2000 Apr 1 ;355(9210):1158-9.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Survival after introduction of HAART in people with known duration of HIV-1 infection. The CASCADE Collaboration. Concerted Action on SeroConversion to AIDS and Death in Europe.

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 17 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information